MYGN

Myriad Genetics, Inc.NASDAQHealthcare

$4.75+3.49%OpenMarket Cap: $444.2M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-02-24	Wells Fargo	—	Equal Weight	—
2026-02-24	UBS	—	Neutral	—
2025-11-11	Piper Sandler	—	Overweight	—
2025-11-05	Wells Fargo	—	Equal Weight	—
2025-11-04	TD Cowen	—	Hold	—
2025-11-04	UBS	—	Neutral	—
2025-05-21	Scotiabank	—	Sector Perform	—
2025-05-15	Piper Sandler	—	Overweight	—
2025-05-08	Wells Fargo	—	Equal Weight	—
2025-05-07	Goldman Sachs	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$0.14	$908.1M	7
Sun Dec 31	$0.24	$956.7M	2
Mon Dec 31	$0.50	$1.00B	1
Tue Dec 31	$0.66	$1.04B	1